ANTX · AN2 Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Braden Michael Leonard 10% Owner | ▼ Sell | Open Market | 3,217,432 Shares held | 5/30/2025 | View profile |
| Readnour Robin Shane Director | ▼ Sell | Open Market | 624,765 Shares held | 9/9/2026 | View profile |
| Adjuvant Global Health Technology Fund, L.P. 10% Owner | ▼ Sell | Open Market | 377,542 Shares held | 1/16/2024 | View profile |
| Eric Easom Chief Executive Officer | ▲ Buy | Grant | 368,630 Shares held | 2/20/2026 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▼ Sell | Open Market | 300,853 Shares held | 8/9/2024 | View profile |
| Joshua M. Eizen Chief Legal Officer | ▼ Sell | Open Market | 206,554 Shares held | 7/8/2026 | View profile |
| Sanjay Chanda Chief Development Officer | ▲ Buy | Grant | 118,823 Shares held | 2/20/2026 | View profile |
| Lucy Day Chief Financial Officer | ▲ Buy | Grant | 118,363 Shares held | 2/20/2026 | View profile |
| Trenor Cameron C. III Chief Medical Officer | ▲ Buy | Grant | 116,667 Shares held | 9/15/2026 | View profile |
| Gilbert Lynn Marks | ▲ Buy | Grant | 81,873 Shares held | 7/10/2026 | View profile |
| Sarah Joanne Williams Principal Accounting Officer | ▼ Sell | Open Market | 66,311 Shares held | 9/1/2026 | View profile |
| Kabeer Aziz Director | ▲ Buy | Grant | 59,106 Shares held | 7/10/2026 | View profile |
| Stephen David Prior Chief Strategy Officer | ▼ Sell | Open Market | 59,086 Shares held | 1/6/2026 | View profile |
| Eckburg Paul Chief Medical Officer | ▲ Buy | Grant | 51,416 Shares held | 3/15/2024 | View profile |
| Krause Kevin Michael Chief Strategy Officer | ▲ Buy | Grant | 31,914 Shares held | 3/15/2024 | View profile |
| Patricia A. Martin Director | ▲ Buy | Grant | 18,863 Shares held | 7/10/2026 | View profile |
| FitzPatrick Margaret M | ▲ Buy | Open Market | 10,708 Shares held | 9/1/2026 | View profile |
| Zakrzewski Joseph S Director | ▼ Sell | Gift | 0 Shares held | 8/14/2026 | View profile |
Transaction History
| Trenor Cameron C. III | ▲ Buy | Grant | 116,667 | $0 | 9/15/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 523 | $3K | 9/9/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 585 | $4K | 9/9/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 4,725 | $28K | 9/8/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 5,294 | $32K | 9/8/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 2,877 | $17K | 9/3/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 3,223 | $20K | 9/3/2026 |
| Sarah Joanne Williams | ▼ Sell | Open Market | 272 | $2K | 9/1/2026 |
| FitzPatrick Margaret M | ▲ Buy | Open Market | 2,098 | $12K | 9/1/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 16,696 | $100K | 8/17/2026 |
| Readnour Robin Shane | ▼ Sell | Open Market | 18,706 | $112K | 8/17/2026 |
| Zakrzewski Joseph S | ▼ Sell | Gift | 405,880 | $0 | 8/14/2026 |
| Kabeer Aziz | ▲ Buy | Grant | 2,852 | $0 | 7/10/2026 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 2,789 | $0 | 7/10/2026 |
| Patricia A. Martin | ▲ Buy | Grant | 766 | $0 | 7/10/2026 |
| Joshua M. Eizen | ▼ Sell | Open Market | 5,945 | $25K | 7/8/2026 |
| Sarah Joanne Williams | ▼ Sell | Open Market | 265 | $1K | 5/29/2026 |
| Kabeer Aziz | ▲ Buy | Grant | 3,775 | $0 | 4/10/2026 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 3,775 | $0 | 4/10/2026 |
| Patricia A. Martin | ▲ Buy | Grant | 1,192 | $0 | 4/10/2026 |
| Sarah Joanne Williams | ▼ Sell | Open Market | 327 | $347 | 3/3/2026 |
| Joshua M. Eizen | ▲ Buy | Grant | 50,000 | $0 | 2/20/2026 |
| Lucy Day | ▲ Buy | Grant | 38,000 | $0 | 2/20/2026 |
| Sarah Joanne Williams | ▲ Buy | Grant | 48,375 | $0 | 2/20/2026 |
| Eric Easom | ▲ Buy | Grant | 112,250 | $0 | 2/20/2026 |
| Sanjay Chanda | ▲ Buy | Grant | 38,000 | $0 | 2/20/2026 |
| Kabeer Aziz | ▲ Buy | Grant | 11,560 | $0 | 1/12/2026 |
| Patricia A. Martin | ▲ Buy | Grant | 3,650 | $0 | 1/12/2026 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 11,560 | $0 | 1/12/2026 |
| Lucy Day | ▼ Sell | Open Market | 5,512 | $6K | 1/6/2026 |
| Sanjay Chanda | ▼ Sell | Open Market | 5,956 | $6K | 1/6/2026 |
| Stephen David Prior | ▼ Sell | Open Market | 2,858 | $3K | 1/6/2026 |
| Joshua M. Eizen | ▼ Sell | Open Market | 6,931 | $7K | 1/6/2026 |
| Lucy Day | ▼ Sell | Open Market | 3,295 | $3K | 1/5/2026 |
| Stephen David Prior | ▼ Sell | Open Market | 3,604 | $4K | 1/5/2026 |
| Sanjay Chanda | ▼ Sell | Open Market | 3,295 | $3K | 1/5/2026 |
| Joshua M. Eizen | ▼ Sell | Open Market | 17,923 | $18K | 1/5/2026 |
| Joshua M. Eizen | ▼ Sell | Open Market | 2,819 | $3K | 11/4/2025 |
| Stephen David Prior | ▼ Sell | Open Market | 765 | $872 | 11/4/2025 |
| Patricia A. Martin | ▲ Buy | Grant | 3,274 | $0 | 10/10/2025 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 10,367 | $0 | 10/10/2025 |
| Kabeer Aziz | ▲ Buy | Grant | 10,367 | $0 | 10/10/2025 |
| Kabeer Aziz | ▲ Buy | Grant | 11,875 | $0 | 7/10/2025 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 11,875 | $0 | 7/10/2025 |
| Patricia A. Martin | ▲ Buy | Grant | 3,750 | $0 | 7/10/2025 |
| Eric Easom | ▲ Buy | Open Market | 10,000 | $11K | 6/2/2025 |
| Braden Michael Leonard | ▼ Sell | Open Market | 425,000 | $429K | 5/30/2025 |
| Braden Michael Leonard | ▼ Sell | Open Market | 7,000 | $7K | 5/30/2025 |
| Braden Michael Leonard | ▼ Sell | Open Market | 200,000 | $218K | 5/28/2025 |
| Braden Michael Leonard | ▼ Sell | Open Market | 2,000,000 | $2.3M | 5/28/2025 |
| Braden Michael Leonard | ▼ Sell | Open Market | 100,000 | $116K | 5/28/2025 |
| FitzPatrick Margaret M | ▲ Buy | Open Market | 8,610 | $10K | 5/28/2025 |
| Zakrzewski Joseph S | ▲ Buy | Grant | 10,523 | $0 | 4/10/2025 |
| Kabeer Aziz | ▲ Buy | Grant | 9,705 | $0 | 4/10/2025 |
| Patricia A. Martin | ▲ Buy | Grant | 3,065 | $0 | 4/10/2025 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 9,705 | $0 | 4/10/2025 |
| Eric Easom | ▲ Buy | Grant | 145,250 | $0 | 2/26/2025 |
| Stephen David Prior | ▲ Buy | Grant | 28,000 | $0 | 2/26/2025 |
| Sanjay Chanda | ▲ Buy | Grant | 50,250 | $0 | 2/26/2025 |
| Lucy Day | ▲ Buy | Grant | 46,500 | $0 | 2/26/2025 |
| Joshua M. Eizen | ▲ Buy | Grant | 58,500 | $0 | 2/26/2025 |
| Lucy Day | ▼ Sell | Open Market | 2,957 | $4K | 1/3/2025 |
| Sanjay Chanda | ▼ Sell | Open Market | 2,957 | $4K | 1/3/2025 |
| Stephen David Prior | ▼ Sell | Open Market | 2,029 | $3K | 1/3/2025 |
| Joshua M. Eizen | ▼ Sell | Open Market | 9,663 | $13K | 1/3/2025 |
| Patricia A. Martin | ▲ Buy | Grant | 3,166 | $0 | 12/19/2024 |
| Kabeer Aziz | ▲ Buy | Grant | 8,972 | $0 | 12/19/2024 |
| Gilbert Lynn Marks | ▲ Buy | Grant | 8,972 | $0 | 12/19/2024 |
| Zakrzewski Joseph S | ▲ Buy | Grant | 9,816 | $0 | 12/19/2024 |
| Readnour Robin Shane | ▲ Buy | Grant | 9,077 | $0 | 12/19/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 5,000 | $7K | 12/10/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 5,000 | $7K | 12/10/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 12,289 | $18K | 12/9/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 18,483 | $26K | 12/9/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 12,711 | $18K | 12/6/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 6,517 | $9K | 12/6/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 25,000 | $35K | 11/27/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 25,000 | $35K | 11/27/2024 |
| Zakrzewski Joseph S | ▲ Buy | Open Market | 2,000 | $3K | 11/27/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 12,500 | $17K | 11/26/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 12,500 | $17K | 11/26/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 25,000 | $29K | 11/20/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 25,000 | $29K | 11/20/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 75,000 | $78K | 11/19/2024 |
| Readnour Robin Shane | ▲ Buy | Open Market | 75,000 | $78K | 11/19/2024 |
| Zakrzewski Joseph S | ▲ Buy | Open Market | 5,000 | $5K | 11/19/2024 |
| Zakrzewski Joseph S | ▲ Buy | Open Market | 20,000 | $20K | 11/18/2024 |
| Eric Easom | ▲ Buy | Open Market | 50,000 | $50K | 11/18/2024 |
| Joshua M. Eizen | ▲ Buy | Grant | 31,500 | $0 | 11/4/2024 |
| Stephen David Prior | ▲ Buy | Grant | 10,125 | $0 | 11/4/2024 |
| Braden Michael Leonard | ▲ Buy | Open Market | 1,500,000 | $1.6M | 8/14/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 3,410,335 | $3.7M | 8/9/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Open Market | 114,759 | $124K | 8/9/2024 |
| Joshua M. Eizen | ▲ Buy | Grant | 60,000 | $0 | 7/10/2024 |
| Lucy Day | ▲ Buy | Grant | 27,500 | $0 | 3/15/2024 |
| Joshua M. Eizen | ▲ Buy | Grant | 30,000 | $0 | 3/15/2024 |
| Krause Kevin Michael | ▲ Buy | Grant | 30,000 | $0 | 3/15/2024 |
| Eckburg Paul | ▲ Buy | Grant | 30,000 | $0 | 3/15/2024 |
| Eric Easom | ▲ Buy | Grant | 99,000 | $0 | 3/15/2024 |
| Sanjay Chanda | ▲ Buy | Grant | 27,500 | $0 | 3/15/2024 |
| Zakrzewski Joseph S | ▼ Sell | Open Market | 100,000 | $1.9M | 1/18/2024 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 84,093 | $1.7M | 1/16/2024 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 15,907 | $313K | 1/16/2024 |
| Kabeer Aziz | ▼ Sell | Open Market | 84,093 | $1.7M | 1/16/2024 |
| Kabeer Aziz | ▼ Sell | Open Market | 15,907 | $313K | 1/16/2024 |
| Readnour Robin Shane | ▼ Sell | Open Market | 706 | $15K | 1/12/2024 |
| Readnour Robin Shane | ▼ Sell | Open Market | 719 | $16K | 1/12/2024 |
| Readnour Robin Shane | ▼ Sell | Open Market | 1,869 | $41K | 1/10/2024 |
| Readnour Robin Shane | ▼ Sell | Open Market | 1,800 | $39K | 1/10/2024 |
| Krause Kevin Michael | ▲ Buy | Option Exercise | 2,417 | $1K | 1/9/2024 |
| Krause Kevin Michael | ▲ Buy | Option Exercise | 5,000 | $33K | 1/9/2024 |
| Krause Kevin Michael | ▼ Sell | Open Market | 7,417 | $149K | 1/9/2024 |
| Krause Kevin Michael | ▲ Buy | Option Exercise | 2,583 | $1K | 1/2/2024 |
| Krause Kevin Michael | ▼ Sell | Open Market | 2,583 | $52K | 1/2/2024 |
| Eric Easom | ▼ Sell | Open Market | 2,777 | $56K | 1/2/2024 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 1,522 | $25K | 11/14/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 288 | $5K | 11/14/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 1,522 | $25K | 11/14/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 288 | $5K | 11/14/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 4,770 | $77K | 10/2/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 902 | $14K | 10/2/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 4,770 | $77K | 10/2/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 902 | $14K | 10/2/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 83,337 | $1.4M | 9/29/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 15,764 | $257K | 9/29/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 83,337 | $1.4M | 9/29/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 15,764 | $257K | 9/29/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 7,160 | $115K | 9/28/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 1,356 | $22K | 9/28/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 7,160 | $115K | 9/28/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 1,356 | $22K | 9/28/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 707 | $11K | 9/27/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 707 | $11K | 9/27/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 134 | $2K | 9/27/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 134 | $2K | 9/27/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 336 | $5K | 9/13/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 336 | $5K | 9/13/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 64 | $1K | 9/13/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 64 | $1K | 9/13/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 2,841 | $46K | 9/7/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 537 | $9K | 9/7/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 2,841 | $46K | 9/7/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 537 | $9K | 9/7/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 3,164 | $51K | 9/6/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 598 | $10K | 9/6/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 3,164 | $51K | 9/6/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 598 | $10K | 9/6/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 336 | $5K | 8/23/2023 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Open Market | 64 | $1K | 8/23/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 336 | $5K | 8/23/2023 |
| Kabeer Aziz | ▼ Sell | Open Market | 64 | $1K | 8/23/2023 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,777,778 | $16.0M | 8/18/2023 |
| Eric Easom | ▲ Buy | Open Market | 10,000 | $54K | 5/15/2023 |
| Eric Easom | ▼ Sell | Open Market | 23 | $346 | 11/14/2022 |
| Eric Easom | ▼ Sell | Open Market | 4,413 | $68K | 11/10/2022 |
| Eric Easom | ▼ Sell | Open Market | 10,111 | $158K | 11/9/2022 |
| Eric Easom | ▼ Sell | Open Market | 5,800 | $89K | 11/8/2022 |
| Eric Easom | ▼ Sell | Open Market | 1,255 | $21K | 11/8/2022 |
| Eric Easom | ▼ Sell | Open Market | 10,167 | $162K | 11/7/2022 |
| Eric Easom | ▼ Sell | Open Market | 2,036 | $34K | 11/7/2022 |
| Eric Easom | ▼ Sell | Open Market | 8,828 | $139K | 11/4/2022 |
| Eric Easom | ▼ Sell | Open Market | 11,082 | $174K | 11/3/2022 |
| Eric Easom | ▼ Sell | Open Market | 3,083 | $49K | 11/3/2022 |
| Eric Easom | ▼ Sell | Open Market | 1,544 | $23K | 11/2/2022 |
| Eric Easom | ▼ Sell | Open Market | 2,688 | $41K | 10/31/2022 |
| Eric Easom | ▼ Sell | Open Market | 1,683 | $25K | 10/28/2022 |
| Eric Easom | ▼ Sell | Open Market | 924 | $14K | 10/27/2022 |
| Eric Easom | ▼ Sell | Open Market | 1,678 | $25K | 10/26/2022 |
| Eric Easom | ▼ Sell | Open Market | 534 | $9K | 10/25/2022 |
| Eric Easom | ▼ Sell | Open Market | 4,272 | $67K | 10/25/2022 |
| Eric Easom | ▼ Sell | Open Market | 2,866 | $46K | 10/24/2022 |
| Eric Easom | ▼ Sell | Open Market | 11,601 | $189K | 10/21/2022 |
| Eric Easom | ▼ Sell | Open Market | 2,350 | $39K | 10/21/2022 |
| Eric Easom | ▼ Sell | Open Market | 7,262 | $121K | 10/20/2022 |
| Eric Easom | ▼ Sell | Open Market | 31 | $532 | 10/20/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 100 | $799 | 8/4/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,809 | $14K | 8/3/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 8,281 | $66K | 7/27/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 14,938 | $115K | 7/26/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 302 | $2K | 6/21/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 61,424 | $489K | 6/14/2022 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 20,000 | $158K | 6/13/2022 |
| Kabeer Aziz | ▼ Sell | Other | 26,511 | $398K | 6/6/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 26,511 | $398K | 6/6/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 26,511 | $398K | 6/6/2022 |
| Kabeer Aziz | ▼ Sell | Other | 26,511 | $398K | 6/6/2022 |
| Readnour Robin Shane | ▼ Sell | Other | 285,156 | — | 3/29/2022 |
| Readnour Robin Shane | ▼ Sell | Other | 333,135 | — | 3/29/2022 |
| Readnour Robin Shane | ▼ Sell | Other | 61,491 | — | 3/29/2022 |
| Readnour Robin Shane | ▲ Buy | Open Market | 70,716 | $1.1M | 3/29/2022 |
| Readnour Robin Shane | ▲ Buy | Open Market | 82,618 | $1.2M | 3/29/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 1,651,636 | — | 3/29/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 312,415 | — | 3/29/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 392,433 | — | 3/29/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▼ Sell | Other | 74,230 | — | 3/29/2022 |
| Adjuvant Global Health Technology Fund, L.P. | ▲ Buy | Open Market | 166,666 | $2.5M | 3/29/2022 |
| Eric Easom | ▼ Sell | Other | 4,907 | — | 3/29/2022 |
| Kabeer Aziz | ▼ Sell | Other | 392,433 | — | 3/29/2022 |
| Kabeer Aziz | ▼ Sell | Other | 74,230 | — | 3/29/2022 |
| Kabeer Aziz | ▲ Buy | Open Market | 166,666 | $2.5M | 3/29/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
AN2 Therapeutics: Failed Drug Potential Value Driver
Seeking Alpha reports that a previously failed drug from AN2 Therapeutics may become a significant value driver for the company. This development is relevant as it suggests potential new revenue or licensing opportunities. The stock is currently trading near its support level, with an average analyst target of $9.00.
AN2 Therapeutics: Failed Drug Potential Value Driver. Seeking Alpha reports that a previously failed drug from AN2 Therapeutics may become a significant value driver for the company. This development is relevant as it suggests potential new revenue or licensing opportunities. The stock is currently trading near its support level, with an average analyst target of $9.00.